Right Versus Left Colon Cancer Biology: Integrating the Consensus Molecular Subtypes
- PMID: 28275039
- DOI: 10.6004/jnccn.2017.0038
Right Versus Left Colon Cancer Biology: Integrating the Consensus Molecular Subtypes
Abstract
Although clinical management of colon cancer generally has not accounted for the primary tumor site, left-sided and right-sided colon cancers harbor different clinical and biologic characteristics. Right-sided colon cancers are more likely to have genome-wide hypermethylation via the CpG island methylator phenotype (CIMP), hypermutated state via microsatellite instability, and BRAF mutation. There are also differential exposures to potential carcinogenic toxins and microbiota in the right and left colon. Gene expression analyses further shed light on distinct biologic subtypes of colorectal cancers (CRCs), with 4 consensus molecular subtypes (CMSs) identified. Importantly, these subtypes are differentially distributed between right- and left-sided CRCs, with greater proportions of the "microsatellite unstable/immune" CMS1 and the "metabolic" CMS3 subtypes found in right-sided colon cancers. This review summarizes important biologic distinctions between right- and left-sided CRCs that likely impact prognosis and may predict for differential responses to biologic therapy. Given the inferior prognosis of stage III-IV right-sided CRCs and emerging data suggesting that anti-epidermal growth factor receptor antibody therapy is associated with worse survival in right-sided stage IV CRCs compared with left-sided cancers, these biologic differences between right- and left-sided CRCs provide critical context and may provide opportunities to personalize therapy.
Copyright © 2017 by the National Comprehensive Cancer Network.
Similar articles
-
Left-Sided microsatellite unstable colorectal cancers show less frequent methylation of hMLH1 and CpG island methylator phenotype than right-sided ones.J Surg Oncol. 2007 Dec 1;96(7):611-8. doi: 10.1002/jso.20877. J Surg Oncol. 2007. PMID: 17786961
-
Metachronous serrated neoplasia is uncommon after right colectomy in patients with methylator colon cancers with a high degree of microsatellite instability.Dis Colon Rectum. 2014 Jan;57(1):39-46. doi: 10.1097/01.dcr.0000437690.18709.76. Dis Colon Rectum. 2014. PMID: 24316944
-
The impact of KRAS mutation, microsatellite instability, and tumor laterality on the prognosis of nonmetastatic colon cancer.Surgery. 2022 Mar;171(3):657-665. doi: 10.1016/j.surg.2021.10.043. Epub 2021 Dec 2. Surgery. 2022. PMID: 34865865
-
Molecular Subtypes of Colorectal Cancer and Their Clinicopathologic Features, With an Emphasis on the Serrated Neoplasia Pathway.Arch Pathol Lab Med. 2016 May;140(5):406-12. doi: 10.5858/arpa.2015-0310-RA. Arch Pathol Lab Med. 2016. PMID: 27128298 Review.
-
Epigenetic alterations in colorectal cancer: the CpG island methylator phenotype.Histol Histopathol. 2013 May;28(5):585-95. doi: 10.14670/HH-28.585. Epub 2013 Jan 23. Histol Histopathol. 2013. PMID: 23341177 Review.
Cited by
-
Prognostic factors and survival disparities in right-sided versus left-sided colon cancer.Sci Rep. 2024 May 29;14(1):12306. doi: 10.1038/s41598-024-63143-3. Sci Rep. 2024. PMID: 38811769 Free PMC article.
-
Clinical outcome and prognostic factors of T4N0M0 colon cancer after R0 resection: A retrospective study.World J Gastrointest Oncol. 2024 May 15;16(5):1869-1877. doi: 10.4251/wjgo.v16.i5.1869. World J Gastrointest Oncol. 2024. PMID: 38764842 Free PMC article.
-
Impact of STAT-signaling pathway on cancer-associated fibroblasts in colorectal cancer and its role in immunosuppression.World J Gastrointest Oncol. 2024 May 15;16(5):1705-1724. doi: 10.4251/wjgo.v16.i5.1705. World J Gastrointest Oncol. 2024. PMID: 38764833 Free PMC article. Review.
-
The histological and molecular characteristics of early-onset colorectal cancer: a systematic review and meta-analysis.Front Oncol. 2024 Apr 26;14:1349572. doi: 10.3389/fonc.2024.1349572. eCollection 2024. Front Oncol. 2024. PMID: 38737895 Free PMC article.
-
Downregulation of NAT1 Expression is Associated with Poor Prognosis and Immune Infiltration in COAD.Pharmgenomics Pers Med. 2024 Apr 16;17:133-148. doi: 10.2147/PGPM.S455490. eCollection 2024. Pharmgenomics Pers Med. 2024. PMID: 38651072 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials